Data to be featured across oral and poster sessions at the Advanced Technologies & Treatments for Diabetes Conference (ATTD) PDUFA target action date for Afrezza in children and adolescents living ...

Introduction Gastroschisis mortality is disproportionately high in Africa due in part to delayed presentation and limited ...

TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in ...

Orsini, a leader in rare disease pharmacy solutions, is pleased to announce it was selected by Immedica Pharma US Inc. as the exclusive specialty pharmacy and hub services partner for LOARGYS® ...

Fans across the world are celebrating SUGA Day as BTS marked the birthday of rapper and producer SUGA with a special tribute video. The heartfelt clip quickly gained attention among fans, highlighting ...

Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on ...

In celebration of Women’s Month, we’re highlighting women leaders who are helping advance the state’s life sciences ecosystem. We asked them to share advice and insights for other women aspiring to ...

We asked podiatrists which shoes they recommended to people with heel pain, then we tested them ourselves to find the most lightweight, cushioning, supportive, and comfortable.

As one B.C. resort town battles a proposed magnesium mine, it fears the project will derail its thriving tourism economy and pose serious health risks ...

Four patients with LGMD-R5 (gamma-sarcoglycanopathy, formerly LGMD-2C) have received the ATA-200 gene therapy as part of the ongoing Phase 1b/2 trial evaluating the safety, pharmacodynamics, and ...

This Sleep Awareness Week, RENPHO, the global leader in smart wellness innovation, is spotlighting one of the most overlooked performance tools in an elite athlete's arsenal: sleep. Rest isn't just ...